| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Mar―26 |
An integrated virtual clinic targeting safe medication access to antiviral treatment during the COVID-19 pandemic |
Stephanie W. Ong, Melissa Chang, Tania Carlyle, Lori Seeton, Shiran Isaacksz, Carolyn Gosse, Christopher T.M. Chan |
| 2 |
[GO] |
2025―Apr―25 |
The gender wage gap in the Canadian pharmacy workforce in the wake of COVID-19 |
Samuel Nemeroff, Neeru Gupta, Pablo Miah |
| 3 |
[GO] |
2024―Nov―15 |
Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists’ perspectives |
Karen Dahri, Kimberley Sinclair (formerly MacNeil), Jolanta Piszczek, Kerry Wilbur, Bryce Wong, I Fan Kuo, Fawziah Marra |
| 4 |
[GO] |
2024―Oct―30 |
British Columbia community pharmacy during COVID-19: Describing the patient experience via Google reviews |
Priya Bains, Fong Chan, James P. McCormack, Aaron Sha |
| 5 |
[GO] |
2024―Aug―15 |
Pharmacists’ prescribing of opioids in Nova Scotia under Health Canada’s Controlled Drugs and Substances Act temporary exemption during the COVID-19 pandemic |
Ronald Watema-Lord, Ingrid Sketris, Heather Neville, Mark Asbridge, Chiranjeev Sanyal |
| 6 |
[GO] |
2023―Jul―31 |
Herpes zoster and human papillomavirus vaccination opportunities identified using electronic prompts at the time of scheduling influenza or COVID-19 vaccines |
Sherilyn K.D. Houle, Mhd. Wasem Alsabbagh, Nancy M. Waite |
| 7 |
[GO] |
2023―Apr―20 |
SARS-CoV-2 rapid diagnostic testing: Canadian consensus guidance for pharmacists |
Aaron Sihota, Brett Barrett, Cameron Bonell, Ahmad Chehade, Jerry Dhaliwal, Michael Kani, Jamie Kellar, Conny Kwong, Pavithra Ravinatarajan, Kevin L. Schwartz, Stacey Smith, Jean Thiffault, Cassandra Woit, Alon Vaisman |
| 8 |
[GO] |
2022―Dec―14 |
Integration of CARD (Comfort Ask Relax Distract) for COVID-19 community pharmacy vaccination in children: Effect on implementation outcomes |
Anna Taddio, James Morrison, Victoria Gudzak, Charlotte Logeman, C. Meghan McMurtry, Lucie M. Bucci, Christine Shea, Noni E. MacDonald, Molly Yang |
| 9 |
[GO] |
2022―Dec―10 |
The COVID conversations: A content analysis of Canadian pharmacy organizations’ communication of pharmacists’ roles and services during the COVID-19 pandemic |
Calli Safnuk, Margaret L. Ackman, Theresa J. Schindel, Kaitlyn E. Watson |
| 10 |
[GO] |
2022―Dec―08 |
Community engagement in a disengaged world: Developing and implementing educational workshops on deprescribing amid the COVID-19 pandemic |
James Conklin, Barbara Farrell, Daniel Dilliott, Lisa Richardson, Lisa McCarthy, Lalitha Raman-Wilms |
| 11 |
[GO] |
2022―Nov―25 |
Experiences of community pharmacists administering COVID-19 vaccinations: A qualitative study |
Sandra Gerges, Victoria Gudzak, Susan Bowles, Charlotte Logeman, Sarah Abu Fadaleh, Lucie M. Bucci, Anna Taddio |
| 12 |
[GO] |
2022―Oct―12 |
Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis |
Ann Chang, Shanzeh Chaudhry, Daniel McCormack, Tara Gomes, Anisa Shivji, Mina Tadrous |
| 13 |
[GO] |
2022―Sep―20 |
COVID-19 vaccination in high-risk communities: Case study of Brampton, Ontario |
Manmohit Gill, Dhruv Datta, Paul Gregory, Zubin Austin |
| 14 |
[GO] |
2022―Feb―08 |
Quacks vs facts: Regulatory body discipline when clinicians spread COVID-19 mis/disinformation |
Ai-Leng Foong-Reichert, Kelly A. Grindrod, Sherilyn K.D. Houle, Zubin Austin |
| 15 |
[GO] |
2021―Dec―17 |
Bloom Program pharmacy teams’ experiences providing mental health services during the COVID-19 pandemic |
Andrea L. Murphy, Katherine Simon, Emilie Pelletier, Laura Miller, David M. Gardner |
| 16 |
[GO] |
2021―Oct―04 |
Changes within an anticoagulation clinic during COVID-19 |
Sydney Selland, Norelle Evanger, Tammy J Bungard |
| 17 |
[GO] |
2021―Jul―10 |
Impact of COVID-19 on frontline pharmacists’ roles and services in Canada: The INSPIRE Survey |
Dillon H. Lee, Kaitlyn E. Watson, Yazid N. Al Hamarneh |
| 18 |
[GO] |
2021―Jun―16 |
Explosive drug information in the time of COVID-19 |
Martin Schulz, Pia M. Schumacher, Juliana Schneider, André Said, Ulrich Laufs |
| 19 |
[GO] |
2021―May―24 |
Telehealth in community pharmacy: A new “place” for the appointment-based model given COVID-19 and the future of health care |
Sara Rezahi, Annalise Mathers, Pooja Patel, Tiana Tilli, Lisa Dolovich |
| 20 |
[GO] |
2021―Apr―19 |
COVID-19 vaccine hesitancy: Pharmacists must be proactive and move the middle |
Kelly Grindrod, Nancy Waite, Cora Constantinescu, Kaitlyn E. Watson, Ross T. Tsuyuki |
| 21 |
[GO] |
2021―Feb―23 |
Pharmacies at the ready: Canada’s pharmacists and the COVID-19 vaccine |
|
| 22 |
[GO] |
2020―Dec―15 |
Introducing a practical tool to reduce fear and anxiety during COVID-19 |
Anna Taddio, Lucie Bucci, C. Meghan McMurtry, Noni MacDonald, Melanie Badali |
| 23 |
[GO] |
2020―Nov―09 |
Influenza immunizations amid COVID-19: The Australia experience |
Sherilyn K.D. Houle |
| 24 |
[GO] |
2020―Oct―15 |
Personal protective equipment: Suggested best practices for pharmacies during the COVID-19 pandemic |
Shelita Dattani, Heather Mohr, Melanie Cann, Kelly A. Grindrod, Kamran Nisar, Smita Patil, Glenn Rodrigues, Deb Saltmarche, Karey Shuhendler, Jeff Whissell |
| 25 |
[GO] |
2020―Oct―07 |
COVID-19 testing by pharmacists |
Ross T. Tsuyuki, Kaitlyn E. Watson |
| 26 |
[GO] |
2020―Aug―14 |
COVID-19: How did community pharmacies get through the first wave? |
Paul A. M. Gregory, Zubin Austin |
| 27 |
[GO] |
2020―Jun―15 |
COVID-19 and the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers |
Megan H. St. John, Arden R. Barry |
| 28 |
[GO] |
2020―Jun―08 |
Pharmacists step up to the challenge of COVID-19 |
Barbara Farrell, Ross T. Tsuyuki |
| 29 |
[GO] |
2020―May―29 |
Role of Canadian pharmacists in managing drug shortage concerns amid the COVID-19 pandemic |
Ali Elbeddini, Naushin Hooda, Lucy Yang |
